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Abstract 
Polymeric bioabsorbable tubes can be used as drug delivery systems and guides for cellular growth in peripheral nerve regeneration. In this 
study polycaprolactone/ibuprofen tubes manufactured by melt extrusion technique were investigated under different screw speeds and 
processing temperatures. To assess the structure and properties of PCL/ibuprofen tubes, analysis was performed using scanning electron 
microscopy, X-ray diffraction, infrared spectroscopy, flexural tests and dynamic mechanical analysis (DMA). The drug delivery profile was 
obtained by determining the in vitro release of ibuprofen. Tubes of PCL/ibuprofen were prepared by vertical extrusion. The average values for 
the diameter and wall thickness of the PCL/ibuprofen tubes were 1.5 mm and 250 µm, respectively. The crystallinity values for the 
PCL/ibuprofen tubes were lower than those for the pure PCL tubes, probably due to the interaction of the drug with the polymer chains. The 
value for the flexural modulus of the PCL/ibuprofen tubes increased with the processing temperature and screw speed, which is probably due to 
better drug dispersion at higher temperature and higher shear rates. The preparation of the tubes using faster screw speeds led to higher values 
being obtained for the storage modulus in the DMA, indicating that the shear rate also affects the mechanical properties. The PCL/ibuprofen 
tubes had lower glass transition temperatures compared with pure PCL tubes, also suggesting interaction between ibuprofen and the PCL 
matrix. The results suggest that the PCL/ibuprofen tubes prepared by vertical extrusion using a screw speed of 17 rpm and processing 
temperature of 140 oC were the most suitable for peripheral nerve regeneration offering appropriate dimensions and mechanical properties and 
an acceptable drug release profile. 
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1. Introduction 
Lesions of the peripheral nervous system are derived from 
crush injuries such as partial or complete nerve transection. It 
is well known that the peripheral nervous system has an 
intrinsic capacity to self-regeneration without surgical 
interference. However, this remarkable feature has proven 
effective only when the distance between the broken ends is 
less than 5 mm [1-5]. When the trauma exceeds this limit 
techniques to aid the recovery are required, such as the use of 
synthetic media, known as nerve guidance conduits, for the 
repair. The advantage of these systems is the possibility of 
joining the ends in cases where the distances are greater than 5 
mm, and also they allow the protection and guidance of the 
cell growth inside the tubes [6-8].  
Polycaprolactone (PCL) is considered to be a very 
favorable material for the development of tubular guides, due 
to its high processability by solvent or melting methods, 
mechanical properties such as flexibility and toughness, 
miscibility with a wide variety of chemical substances and 
biocompatibility [9-11]. PCL devices have been used in 
studies on nerve regeneration and growth. The majority of 
PCL devices are tubes manufactured by electrospun and 
solvent methods which limit the dimensional control and 
reproducibility and, thus, the possibility for industrial 
production [12-14]. Chiono et al. have used the extrusion 
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technique to obtaining PCL tubes and described the industrial 
applicability of this process to produce nerve guides [15]. 
The incorporation of PCL tubes into drug delivery system 
based on an anti-inflammatory molecule can improve the 
control of local acute and chronic inflammations during nerve 
regeneration. Nonsteroidal anti-inflammatory drugs, such as 
ibuprofen, can inhibit the enzyme cyclooxygenase blocking 
myelin fragments which negatively affects axonal 
regeneration after trauma, resulting in better regeneration of 
axons [16, 17].  
In this study, the structure and properties of 
polycaprolactone/ibuprofen tubes were investigated by 
infrared spectroscopy, X-ray diffraction, scanning electron 
microscopy, flexural tests, dynamic mechanical analysis and 
drug release analysis. The structure and properties were 
correlated with the processing conditions. 
 
2. Experimental 
2.1 Materials 
 
In this study the poly(ε-caprolactone) reference 440744 
(Sigma-Aldrich) was used. It was acquired in the form of 
pellets with 3 mm of diameter and average molecular weight 
(Mn) in the range of 70,000 to 90,000 g/mol determined by 
GPC technique. The polydispersity value was less than 2. The 
ibuprofen (IBP) was obtained from Pharmanostra (São Paulo, 
Brazil). The material has the appearance of a white crystalline 
powder with a density of 1.175 g/cm3. The ibuprofen melting 
temperature determined by DSC was 77.4 ºC. 
 
2.2 Melt extrusion process 
 
The extrusion equipment used was a mono-screw extruder 
Axplastic model LAB AX-14 with an L/D ratio of 20. The 
extruder was instrumented with an extrusion die for small 
diameter tubes with an outer diameter of 9.10 mm and inner 
diameter of 7.85 mm. The vertical extrusion process was 
carried out with the aid of an air flow passing through the 
extrusion die. Figure 1 shows a sketch of the extrusion system 
used in the preparation of the PCL/IBP tubes. Table 1 shows 
the processing conditions used in the fabrication of PCL/IBP 
tubes with 15% of ibuprofen content.   
 
 
Fig.1. Sketch of extrusion system. 
 
Table 1: Processing conditions used in the production of the PCL/IBP tubes. 
Factors Low Medium High 
Temperature (oC) 120 130 140 
Screw speed (rpm) 17 20 23 
 Drug content (%) 0 - 15 
 
 
2.3 Scanning electron microscopy (SEM) 
 
XL 30 Philips and JEOL JSM-6390LV scanning electronic 
microscopes were used in the microstructural analysis.  For 
the fracture analysis the samples were mechanically fractured 
in liquid nitrogen (cryogenic fracture). Prior to the analysis by 
SEM, all samples were coated with a thin layer of gold in a 
sputter diode D2 sputtering system. 
 
2.4 X-Ray diffraction and Fourier transform infrared 
analysis (FTIR) 
 
X-ray diffraction analysis was carried out on a Philips 
X’Pert diffractometer. The scan was obtained at 2θ = 5-40° 
directly from the surface of the sample tube positioned 
horizontally. The specimen crystallinity was determined by 
area measurement method [18]. Fourier transform infrared 
spectra of the polymers were obtained using a Frontier 
MIR/NIR Perkin-Elmer spectrophotometer in attenuated total 
reflectance (ATR) mode scanning from 4000 to 450 cm-1.  
 
2.5 Mechanical analysis 
 
A DMA Q800 analyzer (TA instruments) with a single 
cantilever clamp was used for the mechanical tests. A force 
rate of 2N/min from 0 to 18N was applied for quasi-static 
tests. Dynamic mechanic analysis (DMA) was conducted to 
provide the values for the storage (E’), loss modulus (E”) and 
tan delta (δ) at a frequency of 1 Hz within the temperature 
range of -80 to 80 ºC using heating rate of 3 ºC/min and strain 
of 0.3%. The fatigue test was performed applying an 
oscillatory displacement. The amplitude used was 750 µm for 
both directions, at a frequency of 1 Hz and 37 ºC, in order to 
simulate body temperature. The number of cycles until failure 
was obtained considering a strength reduction of 15%.   
 
2.6 Drug release test 
 
The specimens with known drug content and thickness 
were placed in sealed vials with 20 mL of phosphate buffer 
solution (pH = 7.4) and 0.01 M cetyltrimethyl ammonium 
bromide (to maintain sink solubilization conditions) [19-20]. 
The vials were shaken horizontally in a Dubnoff bath (Faalk, 
Brazil) maintained at a temperature of 37.0 ± 0.5 oC at a rate 
of 60 rev/min to minimize the boundary effect. Total buffer 
solutions were collected periodically at predetermined time 
intervals and, after suitable dilution with the buffer solution. 
After suitable dilution with the buffer solution, the total drug 
release was obtained against a predetermined calibration 
curve (five dilutions between 0.050–0.40 mg/mL) using a 
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UV-vis spectrophotometry at Omax of 269 nm, on a Hitachi 
2010 double-beam UV-visible spectrophotometer.  
 
3. Results and discussion 
Figure 2 shows the cryogenic fracture surfaces of the pure 
PCL and PCL/ibuprofen tubes. The measurement of the outer 
diameter and wall thickness for pure PCL and PCL/IBP tubes 
showed dimensions of 1.5 (± 0.2) mm and 250 (± 50) µm, 
respectively. The fracture surface morphologies of the pure 
PCL and PCL/IBP tubes showed similar characteristics. 
However, an increase in the apparent surface roughness was 
observed with the presence of ibuprofen in the PCL matrix. 
 
 
 
 
  
(a)                                                 (b)     
Fig. 2. Cryogenic fractures of pure PCL (a) and PCL/IBP tubes (b). 
 
 
The images in Figure 3 show the outer surfaces of the pure 
PCL and PCL/IBP tubes. The extruded tubes of pure PCL 
presented very low surface roughness (Figure 3a) while a 
significant variation in the surface roughness of the PCL/IBP 
tubes was observed as a function of the processing conditions. 
The PCL/ibuprofen tubes also had small particles and molten 
drug deposited over the surface (Figure 3b-e). The use of the 
EDX technique confirmed the presence of ibuprofen particles 
on the surface of the PCL/IBP tubes in the composition 
analysis of the PCL matrix and the particles (Figure 3f). 
Figure 4 shows the results of the X-ray diffraction analysis 
of the PCL/IBP and pure PCL tubes. The pure PCL 
diffractogram shows two peaks at 2θ 21.6 and 23.8. These 
peaks are indexed to the (110) and (200) planes of an 
orthorhombic crystalline structure [21, 22]. The 
diffractograms of the PCL/IBP tubes showed the same peaks 
at 2θ 21.6 and 23.8. 
The crystallinity values for the pure PCL and PCL/IBP 
tubes are shown in Table 2. It can be observed that the 
crystallinity values for the PCL/IBP tubes were lower than 
that for the pure PCL tube, probably due to interaction of the 
drug with the polymer chains. According to Pant [23] and 
collaborators, the occurrence of this phenomenon is verified 
by the interaction of components at the molecular level, which 
suggests the partial dissolution of ibuprofen in the PCL 
matrix. Higher processing temperatures caused a decrease in 
the crystallinity of the PCL/IBP tubes. 
 
 
 
 
 
(a) 
 
(b) 
 
(c) 
 
(d) 
 
(e)  
(f) 
Fig. 3. Surface scanning electronic micrographs of pure PCL (a) and 
PCL/ibuprofen tubes prepared applying the conditions 17rpm/120ºC (b),  
23rpm/120ºC (c),  17rpm/140ºC (d) and 23rpm/140ºC (e) and EDX analysis 
of PCL matrix and ibuprofen particles (f). 
 
 
 
 
 
 
 
 
 
Fig. 4. Diffractograms of PCL/IBP tubes prepared under different conditions 
of screw speed and processing temperature: 17rpm/120 ºC (a), 23rpm/120 ºC 
(b), 17rpm/140 ºC (c), 23rpm/140 ºC (d), and pure PCL (e). 
Table 2: Crystallinity of pure PCL and PCL/IBP tubes prepared with different 
processing parameters. 
Samples Crystallinity (%) 
Pure PCL 38 
PCL/IBP 17rpm/120ºC  23 
PCL/IBP 23rpm/120ºC  24 
PCL/IBP 17rpm/140ºC 18 
PCL/IBP 23rpm/140ºC  22 
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Figure 5 shows the FTIR spectra for the PCL/IBP tubes 
prepared using different screw speeds and processing 
temperatures (a-d), pure PCL (e) and pure ibuprofen (f). The 
polycaprolactone matrix of the PCL/IBP tubes shows peaks at 
2949, 2863, 1727, 1293, 1170, 1157 and 717 cm-1 related to 
CH2 asymmetric stretching, CH2 symmetric stretching, C=O 
carbonyl stretching, C-O stretching in the crystalline phase, 
asymmetric C-O-C stretching, C-O stretching in the 
amorphous phase and CH2 rocking, respectively [24]. The 
same peaks can be identified in the pure PCL spectrum 
(Figure 5e). The intense band at 2955 cm−1 in the FTIR 
spectra for ibuprofen (Figure 5f) is assigned to CH3 
asymmetric stretching. Peaks of very high intensity at 1721 
cm−1 and 1231 cm−1 are due to C=O stretching, C-O 
stretching, respectively. A band of strong intensity observed 
at 778 cm−1 is related to CH2 rocking vibrations [25]. This 
ibuprofen CH2 rocking band was also observed for the 
PCL/IBP tubes, confirming the drug content (Figure 5a-d). 
 
Fig. 5. FTIR-ATR spectra for PCL/IBP tubes prepared using processing 
conditions of 17rpm/120 ºC (a), 23rpm/120 ºC (b), 17rpm/140 ºC (c), 
23rpm/140 ºC (d), pure PCL (e) and pure ibuprofen (f). 
 
 
The flexural modulus as a function of the processing 
temperature and screw speed used in the production of  
PCL/IBP tubes is shown in Figure 6. The flexural modulus of 
PCL/IBP tubes increased with higher values used for the 
processing temperature and screw speed, probably due to 
better drug dispersion at higher temperatures and shears. 
 
Fig. 6. Flexural modulus values for PCL/IBP tubes versus temperature and 
screw speed. 
Figure 7 reports the results for the fatigue tests showing 
the fatigue behavior (number of cycles to failure) for PCL/IBP 
tubes as a function of the processing temperature and screw 
speed. The processing temperature had a strong influence on 
the fatigue failure. The PCL/IBP tubes produced at higher 
temperatures showed a fast decrease in the stiffness and 
failure due to plastic deformation caused by creep, which is 
probably the result of an unstable ibuprofen and PCL chain 
arrangement. 
Fig. 7. Fatigue failure resistance versus temperature and screw speed for 
PCL/IBP tubes. 
Figure 8 shows the curves for the storage modulus (E') as a 
function of temperature for the PCL/IBP tubes prepared using 
different processing conditions. The storage modulus for the 
PCL/IBP tubes decreased with the DMA test temperature, 
particularly at temperatures close to -50 oC, which relates to 
the PCL glass transition temperature. The tubes prepared 
using higher screw speeds had higher storage modulus values, 
indicating that the shear rate affects the mechanical properties 
of the PCL/IBP tubes, as observed in other drug delivery 
extrudate matrices [26, 27]. 
 
 
Fig. 8. Storage modulus (E') as a function of temperature for PCL/IBP tubes 
produced using different processing conditions: 17rpm/120ºC (a), 
23rpm/120ºC (b), 17rpm/140ºC (c) and 23rpm/140ºC (d). 
 
 
The measurement of the maximum value for the loss 
tangent as a function of temperature (Figure 9) allowed the 
glass transition temperature (Tg) to be determined for the 
PCL/IBP tubes prepared using different processing 
conditions. The PCL/IBP tubes had lower Tg values 
compared with the pure PCL tubes (Table 3). Tubes prepared 
using 23 rpm and 140 °C as the screw speed and processing 
temperature, respectively, had the lowest glass transition 
temperature, suggesting a greater dispersion of ibuprofen in 
the PCL matrix applying these processing conditions. 
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Fig. 9. Values for loss tangent (tan δ) as a function of temperature for 
PCL/IBP tubes prepared using different processing temperatures and screw 
speeds: 17rpm/120ºC (a), 23rpm/120ºC (b), 17rpm/140ºC (c) and 
23rpm/140ºC (d). 
Table 3: Tg values for pure PCL and PCL/ibuprofen tubes obtained from the 
maximum loss tangent in DMA. 
Sample Tg (ºC) 
Pure PCL   -40 
PCL/IBP 17rpm/120ºC  -44 
PCL/IBP 23rpm/120ºC  -42 
PCL/IBP 17rpm/140ºC -43 
PCL/IBP 23rpm/140ºC -48 
 
 
The drug release curves for PCL/IBP tubes prepared 
applying different processing conditions are shown in Figure 
10. The tubes produced using lower processing temperatures 
(Figure 10a-b) showed a fast ibuprofen release during the first 
few days, but a lower total quantity of ibuprofen was released, 
indicating greater loss of ibuprofen during the tube 
preparation (50 to 55%). The PCL/IBP tubes prepared 
applying 17 rpm and 140 °C as the screw speed and 
processing temperature, respectively, (Figure 10c) provided 
appropriate drug release behavior, with fast drug release in the 
first 5 days followed by controlled release from 5 to 30 days. 
 
 
Fig. 10.  Ibuprofen release as a function of time for tubes prepared applying 
different screw speeds and processing temperatures: 17rpm/120ºC (a), 
23rpm/120ºC (b), 17rpm/140ºC (c) and 23rpm/140ºC (d).  
 
 
The drug release curves for PCL/IBP tubes prepared 
applying different processing conditions are shown in Figure 
10. The tubes produced using lower processing temperatures 
(Figure 10a-b) showed a fast ibuprofen release during the first 
few days, but a lower total quantity of ibuprofen was released, 
indicating greater loss of ibuprofen during the tube 
preparation (50 to 55%). The PCL/IBP tubes prepared 
applying 17 rpm and 140 °C as the screw speed and 
processing temperature, respectively, (Figure 10c) provided 
appropriate drug release behavior, with fast drug release in the 
first 5 days followed by controlled release from 5 to 30 days. 
4. Conclusions 
PCL/IBP tubes were prepared by vertical extrusion with 
average values for the diameter and wall thickness of 1.5 (± 
0.2) mm and 250 (± 50) µm, respectively. The SEM-EDX 
analysis verified the presence of ibuprofen particles on the 
surface of the PCL/IBP tubes. The ibuprofen CH2 rocking 
band at 778 cm-1 was present on the FTIR spectra obtained 
for the PCL/IBP tubes, confirming the drug content. The 
PCL/IBP tubes had lower crystallinity values than pure PCL 
tubes, probably due to the interaction of the drug with the 
polymer chains. The use of higher processing temperatures 
caused a decrease in the crystallinity of the PCL/IBP tubes. 
The flexural modulus of the PCL/IBP tubes increased with 
an increase in the processing temperature and screw speed, 
probably due to better drug dispersion at higher temperatures 
and shears. On the other hand, an increase in the processing 
temperature caused a reduction in the fatigue properties 
(number of cycles to failure) of the PCL/IBP tubes. The tubes 
prepared using higher screw speeds presented higher values 
for the storage modulus in the DMA, indicating that the shear 
rate also affected the mechanical properties. The PCL/IBP 
tubes had lower glass transition temperatures than the pure 
PCL tubes, suggesting interaction between ibuprofen and the 
PCL matrix. 
The tubes prepared using the lowest processing 
temperature (120 °C) showed fast drug release during the first 
few days but a lower total quantity of ibuprofen was released 
(50 to 55% was lost in the preparation). The PCL/IBP tubes 
prepared using a 17 rpm screw speed and processing 
temperature of 17 rpm and 140 °C, respectively, showed fast 
drug release in the first 5 days followed by controlled release 
until day 30, with 75% of the ibuprofen being released. In the 
case of peripheral nerve regeneration, the drug delivery 
profile is of interest in relation to minimizing the 
inflammatory process caused by the insertion of the tube and 
nerve repair trauma. The PCL/IBP tubes prepared by vertical 
extrusion using a screw speed of 17 rpm and processing 
temperature of 140 oC were the most suitable for peripheral 
nerve regeneration, presenting appropriate dimensions and 
mechanical properties and a suitable drug release profile. 
Acknowledgements 
The authors would like to thank PRONEX/FAPESC, 
CNPQ and FINEP by the financial support, and the Center of 
Microscopy-UFSC for the micrographics. 
 
198   G.V. Salmoria et al. /  Procedia CIRP  49 ( 2016 )  193 – 198 
References 
[1] C. Cunha; S. Panseir; S. Antonini. Emerging nanotechnology approaches 
in tissue engineering for peripheral nerve regeneration. Nanomedicien: 
Nanotechnology, Biology and Medicine 7 (2011) 50-59. 
[2] L. Yao; G.C.W. Ruier; H. Wang; A.M. Knight; R.J. Spinner; M.J. 
Yaszemski; A.J. Windebrank; A. Pandit. Controlling dispersion of axonal 
regeneration using a multichannel collagen nerve conduit. Biomaterials 31 
(2010) 5789-5797. 
[3] D. Yucel; G.T. Kose; V. Hasirci. Polyester based nerve guidance conduit 
design. Biomaterials 31 (2010) 1596-1603. 
[4] M.B. Runge; M. Dadsetan; J. Baltrusaits; A.M. Knight; T. Ruesink; E.A. 
Lazcano; L. Lu; A.J. Windebank; M.J. Yaszemski. The development of 
electrically conductive polycaprolactone fumarate-polypyrrole composite 
materials for nerve regeneration. Biomaterials 31 (2010) 5916-5926. 
[5] J.S. Belkas; M.S. Shoichet; R. Midha. Axonal guidance channels in 
peripheral nerve regeneration. Operative Techniques in Orthopaedics 14 
(2004) 190-198. 
[6] S.H. Hsu; W.C. Kuo; Y.T. Chen; C.T. Yen; Y.F. Chen; K.S. Chen; W.C. 
Huang; H. Cheng. New nerve regeneration strategy combining laminin-
coated chitosan conduits and stem cell therapy. Acta Biomaterialia 9 (2013) 
6606-6615. 
[7] X.F. Zhang; A. Coughlan; H. O’Shea; M.R. Towler; S. Kehoe; D. Boyd. 
Experimental composite guidance conduits for peripheral nerve repair: an 
evaluation of ion release. Materials Science and Engineering C 32 (2012) 
1654-1663. 
[8] C.Y. Wang; K.H. Zhang; C.Y. Fan; X.M. Mo; H.J. Ruan; F.F. Li. Aligned 
natural-synthetic polyblend nanofibers for peripheral nerve regeneration. Acta 
Biomaterialia 7 (2011) 634-643. 
[9] F. Rezgui; M. Swistek; J.M. Hiver; G.G. Sell; T. Sadoun. Deformation 
and damage upon stretching of degradable polymers (PLA and PCL). 
Polymer 46 (2005) 7370-7385. 
[10] F.M. Da Silva. Desenvolvimento, caracterização e estudo pré-clínico de 
dispositivos implantáveis biocompatíveis baseados no polímero poli (ε-
caprolactona) (2011) 156f. Doctoral Thesis (Tecnologia Nuclear – 
Aplicações), Universidade de São Paulo, São Paulo. 
[11] T.W. Chung; M.C. Yang; C.C. Tseng; S.H. Sheu; S.S. Wang; Y.Y. 
Huang; S.D. Chen. Promoting regeneration of peripheral nerves in-vivo using 
new PCL-NGF/Tirofiban nerve conduits. Biomaterials 32 (2011) 734-743. 
[12] S. Hsu; S. Chan; C. Chiang; C.C. Chen; C. Jiang. Peripheral nerve 
regeneration using a microporous polylactic acid asymmetric conduit in a 
rabbit long-gap sciatic nerve transaction model. Biomaterials 32 (2011) 3764-
3775. 
[13] Ao, Q.; Fung, C.K.; Tsui, A.Y.P.; Zuo, H.C.; Chan, Y.S.; Shum, D.K.Y. 
The regeneration of transected sciatic nerves of adult rats using chitosan 
nerve conduits seeded with bone marrow stromal cell-derived Schwann cells. 
Biomaterials 32 (2011) 787- 796. 
[14] J.T. Oliveira; F.M. Almeida; A. Biancalana; A.F. Baptista; M.A. Tomaz; 
P.A. Melo; A.M.B. Martinez. Mesenchymal stem cells in a polycaprolactone 
conduit enhance median-nerve regeneration, prevent decrease of creatine 
phosphokinase levels in muscle, and improve functional recovery in mice. 
Neuroscience 170 (2010) 1295-1303. 
[15] V. Chiono; G. Vozzi; F. Vozzi; C. Salvadori; F. Dini; F. Carlucci; M. 
Arispici; S. Burchielli; F. Di Scipio; S. Geuna; M. Fornaro; P. Tos; S. 
Nicolino; C. Audisio; I. Perroteau; A. Chiaravalloti; C. Domenici; P. Giusti; 
G. Ciardeli. Melt-extruded guides for peripheral nerve regeneration. Part I: 
Poly(ε-caprolactone). Biomed Devices 11 (2009) 1037-1059. 
[16] C.R. Camara-Lemarroy; E.I. Gonzalez-Moreno; F.J. Guzman-Garza; 
N.E. Fernadez-Garza. Arachidonic acid derivatives and their role in 
peripheral nerve degeneration and regeneration. Scientific World Journal 
(2012)  1-7. 
[17] A. Gryczke; S. Schminke; M. Maniruzzaman; J. Beck; D. Douroumis. 
Development and evaluation of orally disintegrating tablets (ODTs) 
containing ibuprofen granules prepared by hot melt extrusion. Colloids and 
Surface B: Biointerfaces 86 (2011) 275-284. 
[18] Gean V. Salmoria, Carlos H. Ahrens, Felix A. Y. Villamizar, Aurélio da 
C. Sabino Netto. Thermal Behavior of Epoxy/Aluminum Rapid Tooling 
Composite During Injection Molding of Polypropylene. Polímeros: Ciência e 
Tecnologia, vol. 18, nº 3, (2008) 262-269. 
[19] G.V. Salmoria, P.Klauss, K. Zepon, L. A.Kanis, C. R. M. Roesler, L. F. 
Vieira. Development of functionally-graded reservoir of PCL/PG by selective 
laser sintering for drug delivery devices. Virtual and Physical Prototyping, 
vol. 7, no. 2 (2012) 107–115. 
 
[20] G. V. Salmoria, P. Klauss, K.M. Zepon, L. A. Kanis. The effects of laser 
energy density and particle size in the selective laser sintering of 
polycaprolactone/progesterone specimens: morphology and drug release. 
International Journal of Advanced Manufacturing Technology, vol. 66, no. 5–
8, (2013) 1113–1118. 
 
[21] A. Baji, S.C. Wong, T. Liu, T. Li, T.S. Srivatsan, J. Morphological and 
X-ray diffraction studies of crystalline hydroxyapatite-reinforced 
polycaprolactone. Biomed. Mat. Res. Part B Appl. Biomater. 81B (2) (2007) 
343–350. 
 
[22] M.S.S.B. Monteiro, F.V. Chávez, P. J. Sebastião, M.I.B. Tavares. 1H 
NMR relaxometry and X-ray study of PCL/nevirapine hybrids Polymer 
Testing 32 (2013) 553–566. 
 
[23] H.R. Pant; M.P. Neupane; B. Pant; G. Panthi; H. Oh; M.H. Lee; H.Y. 
Kim. Fabrication  of  highly  porous  poly  (ε-caprolactone) fibers for novel 
tissue scaffold via water-bath electrospinning. Colloids and Surfaces B: Bio-
interfaces 88 (2011) 587-592. 
 
[24] Paquet, O.; Krouit, M.; Bras, J.; Thilemans, W.; Belgacem, M. Surface 
modification of cellulose by PCL grafts. Acta Materialia, v. 58, (2010) 792-
801. 
 
[25] Mallick, S.; Pradhan, S.K.; Chandran, M.; Acharya, M.; Digdarsini, T.; 
Mohapatra, R. Study of particle rearrangement, compression behavior and 
dissolution properties after melt dispersion of ibuprofen, Avicel and Aerosil. 
Results in Pharma Science, v.1 (2011) 1-10. 
 
[26] K. M. Zepon, L. F. Vieira, V. Soldi, G. V. Salmoria, L. A. Kanis. 
Influence of process parameters on microstructure and mechanical properties 
of starch-cellulose acetate/silver sulfadiazine matrices prepared by melt 
extrusion. Polymer Testing 32 (2013) 1123–1127. 
 
[27] K. M. Zepon, F. Petronilho, V. Soldi, G. V. Salmoria, L. A. Kanis. 
Production and characterization of cornstarch/cellulose acetate/silver 
sulfadiazine extrudate matrices. Materials Science and Engineering C 44 
(2014) 225–233. 
 
